U.S. imports of Other Antibiotic Medicaments, Dosage Form or Retail Packings (SITC 54219) totaled $108.4M in August 2026, imported from 32 countries.
Importers of Other Antibiotic Medicaments, Dosage Form or Retail Packings paid $203K in duties in August 2026, an average duty rate of 0.19% — duty actually collected as a share of the imports that cleared customs, not the published tariff schedule. Other Antibiotic Medicaments, Dosage Form or Retail Packings imports of $108.4M in August 2026 ran 13% below the year-to-date monthly average of $125.2M.
Last updated: August 2026 dataFinished medicaments containing antibiotics other than penicillins and streptomycins — including macrolides, fluoroquinolones, tetracyclines, and cephalosporins — in measured doses or retail packaging are classified here, making this one of the broadest finished-antibiotic headings in the SITC schedule. FDA admissibility review governs all such imports, with particular scrutiny on generic drug manufacturers' cGMP compliance and bioequivalence data. The NES scope means classification disputes can arise when a product contains multiple antibiotic classes; the primary active ingredient typically governs. These finished products serve hospital, retail pharmacy, and veterinary distribution channels.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
730 import shipments a month
FDA may place a foreign drug manufacturer on an import alert, which subjects all shipments from that establishment to detention without physical examination. Importers should verify the manufacturer's compliance status in FDA's import alert database before placing orders, as detained shipments can result in significant delays and re-exportation costs.
Classification of combination antibiotic products can be complex and depends on which active ingredient is considered primary under the applicable classification rules. This is a genuine edge case where a licensed customs broker or trade attorney should be consulted, as misclassification can result in duty underpayment or overpayment and potential CBP penalties.
Basic heading 32 of 465 in section 5
Basic heading 54219 · $108.4M of $27.5B
Trade Directory
List your company and tag the 6-digit products you trade, so the companies trading them can find you. Be the first supplier listed.
Imports · August 2026
origin
India and Italy together supply 59% of it.
customs district
Census does not publish district detail for this classification system.
destination
Census does not publish state detail for this classification system.
entry
Census does not publish port detail for this classification system.
ImportsExports
Imports
$108.4MYoY · free account
Exports
$70.3MYoY · free account
12-mo low · imports
Low · free accountOver the twelve months to August 2026, the U.S. imported $1.4B of Other Antibiotic Medicaments, Dosage Form or Retail Packings and exported $1.0B.
Through August 2026. Source: U.S. Census Bureau.